Form 4: Hims & Hers Chief Legal Officer Sells Shares Under Pre-Arranged 10b5-1 Plan

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, sold 2,572 shares of Class A Common Stock for $58.7 per share as part of a pre-arranged 10b5-1 trading plan.

Summary

• Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), reported a sale of company stock.
• On July 28, 2025, 2,572 shares of Class A Common Stock were sold.
• The shares were sold at a price of $58.7 per share.
• Following this transaction, Soleil Boughton beneficially owns 155,593 shares of Class A Common Stock.
• The sale was executed under a Rule 10b5-1 trading plan, which was adopted on August 28, 2024.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan, which is a common practice for executive financial planning and does not inherently indicate a change in company sentiment or performance.

Positives

• The sale was conducted pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction for personal financial planning rather than an ad-hoc sale based on new information.

Negatives

• An insider sale, even if pre-planned, reduces the direct equity ownership of a key executive in the company.

Future Outlook

This Form 4 filing reports a specific insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing details a routine insider stock transaction for Hims & Hers Health, Inc. and does not provide information directly related to broader industry trends or competitive dynamics. Such transactions are common across various industries for executive financial planning.

Stakeholder Impact

• Shareholders: May view the insider sale with slight caution, though the pre-planned nature under a 10b5-1 plan mitigates concerns about immediate negative implications for the company's prospects.

Key Dates

Recommendation

The filing details a pre-scheduled stock sale by a company officer under a Rule 10b5-1 plan. Such transactions are common for personal financial planning and do not typically signal a change in the company's fundamental outlook or warrant an immediate shift in investment strategy. Therefore, a 'hold' recommendation is appropriate as this specific filing does not provide new information to alter the existing investment thesis.

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Sale, Soleil Boughton, Chief Legal Officer, 10b5-1 Plan, Equity Transaction